Literature DB >> 25895977

Goal-directed therapy for cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: the right approach in the right place.

Federico Piccioni1, Kusamura Shigeki, Martin Langer.   

Abstract

Mesh：

Year:  2015        PMID： 25895977     DOI： 10.1007/s11605-015-2819-y

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN： 1091-255X            Impact factor:   3.452


× No keyword cloud information.
  6 in total

Review 1.  A systematic review and meta-analysis on the use of preemptive hemodynamic intervention to improve postoperative outcomes in moderate and high-risk surgical patients.

Authors:  Mark A Hamilton; Maurizio Cecconi; Andrew Rhodes
Journal:  Anesth Analg       Date:  2010-10-21       Impact factor: 5.108

2.  A randomized trial of goal directed vs. standard fluid therapy in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.

Authors:  Luca Colantonio; Claudia Claroni; Luana Fabrizi; Maria Elena Marcelli; Maria Sofra; Diana Giannarelli; Alfredo Garofalo; Ester Forastiere
Journal:  J Gastrointest Surg       Date:  2015-01-17       Impact factor: 3.452

Review 3.  Meta-analysis of hemodynamic optimization in high-risk patients.

Authors:  Jack W Kern; William C Shoemaker
Journal:  Crit Care Med       Date:  2002-08       Impact factor: 7.598

4.  Safety of epidural analgesia in the perioperative care of patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.

Authors:  Pascal Owusu-Agyemang; Jose Soliz; Andrea Hayes-Jordan; Nusrat Harun; Vijaya Gottumukkala
Journal:  Ann Surg Oncol       Date:  2013-08-28       Impact factor: 5.344

5.  Post-operative critical care management of patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy (HIPEC).

Authors:  Timothy J Cooksley; Philip Haji-Michael
Journal:  World J Surg Oncol       Date:  2011-12-19       Impact factor: 2.754

6.  Clinical review: Goal-directed therapy-what is the evidence in surgical patients? The effect on different risk groups.

Authors:  Maurizio Cecconi; Carlos Corredor; Nishkantha Arulkumaran; Gihan Abuella; Jonathan Ball; R Michael Grounds; Mark Hamilton; Andrew Rhodes
Journal:  Crit Care       Date:  2013-03-05       Impact factor: 9.097
  6 in total
  2 in total

1.  Reply to authors' letter for the manuscript entitled: "goal-directed therapy for cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: the right approach in the right place".

Authors:  Claudia Claroni; Giulia Torregiani; Marco Covotta; Ester Forastiere
Journal:  J Gastrointest Surg       Date:  2015-04-23       Impact factor: 3.452

2.  Association of Fluid Administration With Morbidity in Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy.

Authors:  Oliver S Eng; Sinziana Dumitra; Michael O'Leary; Mustafa Raoof; Mark Wakabayashi; Thanh H Dellinger; Ernest S Han; Stephen J Lee; I Benjamin Paz; Byrne Lee
Journal:  JAMA Surg       Date:  2017-12-01       Impact factor: 14.766
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.